Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.48 by 8.33 percent. This is a 8.33 percent increase over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $3.89 billion which missed the analyst consensus estimate of $4.00 billion by 2.78 percent. This is a 1.89 percent increase over sales of $3.82 billion the same period last year.